Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Increased cathepsin B activity in peripheral blood mononuclear cells of multiple sclerosis patients.

Bever CT Jr, Panitch HS, Johnson KP.

Neurology. 1994 Apr;44(4):745-8.

PMID:
8164836
2.

Increased cathepsin B activity in multiple sclerosis brain.

Bever CT Jr, Garver DW.

J Neurol Sci. 1995 Jul;131(1):71-3.

PMID:
7561950
3.

Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis.

Sarchielli P, Orlacchio A, Vicinanza F, Pelliccioli GP, Tognoloni M, Saccardi C, Gallai V.

J Neuroimmunol. 1997 Dec;80(1-2):76-86.

PMID:
9413261
4.

Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.

Mix E, Stefan K, Höppner J, Klauer T, Zettl UK, Strauss U, Meyer-Rienecker HJ, Rolfs A.

Autoimmunity. 2003 Aug;36(5):291-305.

PMID:
14567559
5.

Expression of Fc epsilon R2/CD23 and p55 IL-2R/CD25 on peripheral blood macrophages/monocytes in multiple sclerosis.

Tsukada N, Miyagi K, Matsuda M, Yanagisawa N.

J Neuroimmunol. 1994 Dec;55(2):127-33.

PMID:
7530259
6.
7.
8.

pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.

Frisullo G, Angelucci F, Caggiula M, Nociti V, Iorio R, Patanella AK, Sancricca C, Mirabella M, Tonali PA, Batocchi AP.

J Neurosci Res. 2006 Oct;84(5):1027-36.

PMID:
16865709
10.

Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis.

Pashenkov M, Mustafa M, Kivisäkk P, Link H.

Scand J Immunol. 1999 Sep;50(3):302-8.

11.

Cathepsin D activity in human peripheral blood mononuclear leukocytes.

Bever CT Jr, Morgan KD, Whitaker JN.

Inflammation. 1989 Jun;13(3):309-16.

PMID:
2787785
12.

Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE.

J Clin Virol. 2000 May;16(3):179-91.

PMID:
10738137
13.

Cathepsin D, B and L circulating levels as prognostic markers of malignant progression.

Tumminello FM, Leto G, Pizzolanti G, Candiloro V, Crescimanno M, Crosta L, Flandina C, Montalto G, Soresi M, Carroccio A, Bascone F, Ruggeri I, Ippolito S, Gebbia N.

Anticancer Res. 1996 Jul-Aug;16(4B):2315-9. Erratum in: Anticancer Res 1996 Nov-Dec;16(6C):4003.

PMID:
8694562
15.

Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.

Ysrraelit MC, Gaitán MI, Lopez AS, Correale J.

Neurology. 2008 Dec 9;71(24):1948-54. doi: 10.1212/01.wnl.0000336918.32695.6b.

PMID:
19064876
16.

Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.

Liu GZ, Gomes AC, Putheti P, Karrenbauer V, Kostulas K, Press R, Hillert J, Hjelmström P, Gao XG.

Scand J Immunol. 2006 Oct;64(4):412-9.

17.
18.
19.

Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis.

Macchi B, Matteucci C, Nocentini U, Caltagirone C, Mastino A.

Neuroreport. 1999 Feb 5;10(2):399-402.

PMID:
10203342
20.

Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.

Ozenci V, Kouwenhoven M, Huang YM, Xiao B, Kivisäkk P, Fredrikson S, Link H.

Scand J Immunol. 1999 May;49(5):554-61.

Supplemental Content

Support Center